Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
What Torrent files
- Others113
- Investor Meet33
- Updates31
- Important30
- Dividend/Bonus14
- QIP/Rights/Pref.12
Torrent Pharmaceuticals has announced its audited financial results for the quarter and year ended March 31, 2026. **Business Performance:** The company delivered robust revenue growth. For Q4 FY26, total revenues surged 42% year-over-year to 4,197 Cr. The full fiscal year 2026 also saw strong performance, with total revenues rising 21%...
Torrent Pharma reported Q3 FY26 total revenue of Rs 3303 Cr, marking an 18% year-on-year growth. For the nine months ending Dec 25, total revenue reached Rs 9783 Cr, a 14% increase from the previous year. Geographically, Brazil was a standout performer in Q3, growing 27% YoY to Rs 371...
**1. Financial Highlights:** Torrent Pharma reported a solid 11% year-on-year growth in total consolidated revenues for Q1 FY26, reaching Rs 3,178 Cr, up from Rs 2,859 Cr in Q1 FY25. The India business led the charge with a robust 19% growth. Key markets like Germany, Brazil, and Others segments also...
1. Financial Highlights: Torrent Pharmaceuticals is acquiring a 46.39% stake in JB Chemicals & Pharmaceuticals for INR 11,917 Cr, implying significant capital deployment. JB Pharma reported FY25 revenues of INR 3,918 Cr with a CAGR of 18% over recent years. The business mix is balanced with 58% from India, 29%...
1. Financial Highlights: Torrent Pharmaceuticals posted Q4 revenues of ₹2,959 Cr, up 8% YoY, led by strong growth in India (+12%) and the US (+15%). Full-year revenue increased 7% to ₹11,516 Cr, with India driving growth at 13%. Brazil experienced a modest decline (-6% Q4, -2% FY), while Germany and...